Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | PJ353 | — |
Shingrix vaccine was reconstituted with a diluent from an MMR vaccine instead of the adjuvant that comes with Shingrix; Shingrix vaccine was reconstituted with a diluent from an MMR vaccine instead of the adjuvant that comes with Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number PJ353) for prophylaxis. On 19-JUN-2025, the patient received Shingrix. On 19-JUN-2025, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Shingrix vaccine was reconstituted with a diluent from an MMR vaccine instead of the adjuvant that comes with Shingrix) and inappropriate dose of vaccine administered (Verbatim: Shingrix vaccine was reconstituted with a diluent from an MMR vaccine instead of the adjuvant that comes with Shingrix). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 20-JUN-2025 The healthcare professional reported that a Shingrix vaccine was reconstituted with a diluent from an MMR vaccine instead of the adjuvant that comes with Shingrix which led to Wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered. The final product was administered to the patient.